Elanco (ELAN) Financial Analysis & Valuation | Quarter Chart
Elanco (ELAN)
ELANPrice: $24.74
Fair Value: 🔒
🔒score
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto... more
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and ... more
Description
Shares
| Market Cap | $12.36B | Exchange | NYSE |
| Sector | Healthcare | Industry | Drug Manufacturers - Specialty & Generic |
| Country | US | CEO | Jeffrey N. Simmons |
| IPO Date | 2018-09-20 | CAGR | 0.05% |
| Employees | 9,000 | Website | www.elanco.com |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | — | Total Yield | — |
ELAN chart loading...
Fundamentals
Technicals
| Enterprise Value | $16.98B | P/E Ratio | 25.24 |
| Forward P/E | 20.81 | PEG Ratio | — |
| P/S Ratio | 2.88 | P/B Ratio | 2.15 |
| P/CF Ratio | 24.3 | P/FCF Ratio | 44.65 |
| EPS | $0.98 | EPS Growth 1Y | — |
| EPS Growth 3Y | — | EPS Growth 5Y | — |
| Revenue Growth 1Y | 10.53% | Gross Margin | 0.49% |
| Operating Margin | 0.09% | Profit Margin | -0.05% |
| ROE | -0.04% | ROA | -0.02% |
| ROCE | 0.04% | Current Ratio | 2.16 |
| Quick Ratio | 1.12 | Cash Ratio | 0.26 |
| Debt/Equity | 0.61 | Interest Coverage | 1.62 |
| Altman Z Score | 1.48 | Piotroski Score | 5 |